GLP-1 vs Insulin Lispro

Head-to-head comparison of GLP-1 (Glucagon-like peptide-1 (7-36 amide)) and Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1Insulin Lispro
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagon-like peptide-1 (7-36 amide)Insulin lispro (B28-Lys, B29-Pro human insulin analog)
Molecular Weight3297 Da5808.0 Da
Half-Life1-2 minutesAbout 1 hour
Amino Acids3051
Typical DoseResearch-only: 0.1-1.0 pmol/kg/min0.05-0.2 U/kg per meal
RouteIntravenous/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count120012000
Research StatusPre-clinicalApproved

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Lispro Benefits

  • Rapid postprandial glucose control
  • Flexible premeal timing
  • Predictable onset of action
  • Useful in basal-bolus regimens

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Lispro Dosing

Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Insulin Lispro Side Effects

  • Hypoglycemia
  • Weight gain
  • Injection-site reactions

Research Overview

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Insulin Lispro

Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise

Insulin Lispro stacks with:

Insulin GlargineInsulin Degludec
incretinbeta-cell survivalDPP-4 substraterapid-acting insulinprandial controlglucose regulation